Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design

Publication

Citation
Cheng H., Li C., Bailey S., Baxi S., Goulet L., Guo L., Hoffman J., Jiang Y., Johnson T., Johnson T., Knighton D., Li J., Liu K., Liu Z., Marx M., Walls M., Wells P., Yin M., Zhu J., Zientek M.: Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design. ACS Medicinal Chemistry Letters, Volume 4 (1), 2012
Authors
Hengmiao Cheng, Chunze Li, Simon Bailey, Sangita M. Baxi, Lance Goulet, Lisa Guo, Jacqui Hoffman, Ying Jiang, Theodore Otto Johnson, Ted W. Johnson, Daniel R. Knighton, John Li, Kevin K.-C. Liu, Zhengyu Liu, Matthew A. Marx, Marlena Walls, Peter A. Wells, Min-Jean Yin, Jinjiang Zhu, Michael Zientek
Journal
ACS Medicinal Chemistry Letters
Year
2012
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc